ESC 2007: Glycoprotein IIIa gene allele may lead to better choice of stent
This article was originally published in Clinica
Executive Summary
Testing for a polymorphism of the gene for glycoprotein IIIa (GPIIIa) in patients scheduled for percutaneous coronary intervention (PCI) could help physicians decide whether to use a bare metal stent (BMS) rather than a drug-eluting stent (DES).